About MMI

Company Vision: 
MMI will leverage its base memory metal technology and other development platforms to become the leader in extremity orthopaedics. It is our goal to bring new products to the market that improve the surgeon’s clinical practice, hospital/surgery center efficiencies and patient outcomes.

Company History: 
MMI is the U.S. Subsidiary of Memometal Technologies.  Founded in 1992, Memometal Technologies is one of the only fully integrated manufacturers of Nitinol (NiTi) in the world.  Memometal produces their Nitinol products from raw material (melting) to the final sterile implant.

In 2002, Memometal Technologies began a strategic effort to concentrate its core technology and efforts in the extremity market (foot/ankle and hand/wrist/elbow).  Since then Memometal Technologies has rapidly grown with offices in the following countries: 

The company is independent, privately held and registered in France.